Stocks Industrials CBIH
OTC · IndustrialsCannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. brought in $123.6K of revenue over the twelve months to February 28, 2026, down 64.1% from a year earlier. It posted a net loss of $515.3K. At February 28, 2026 it held $90 in cash against $290.9K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on April 16, 2026.
Watch CBIH in 60 secondsWhat Cannabis Bioscience International Holdings, Inc. does
Cannabis Bioscience International Holdings, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on OTC under the ticker CBIH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $303K | -$548.8K | -$0.00 | n/a |
| 2024 | $248.8K | -$651.3K | -$0.00 | n/a |
| 2024 | $316.8K | -$1M | -$0.00 | n/a |
Full financial statements: income, balance sheet and cash flow
Where CBIH ranks in Industrials
Latest SEC filings
What Cannabis Bioscience International Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 31, 2026Late annual report notice NT 10-K
- July 1, 2026Form 253G2 filing 253G2
- May 21, 2026Form 253G2 filing 253G2
- April 16, 2026Quarterly report 10-Q · period to February 28, 2026Revenue fell 25% to $11.2K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- April 15, 2026Form 253G2 filing 253G2
- April 14, 2026Late quarterly report notice NT 10-Q
- April 13, 2026Form QUALIF filing QUALIF
- March 27, 2026Form 1-A filing 1-A
- February 19, 2026Quarterly report 10-Q · period to November 30, 2025Revenue fell 28% to $53.3K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- January 14, 2026Late quarterly report notice NT 10-Q
Questions about CBIH
What does Cannabis Bioscience International Holdings, Inc. do?
Cannabis Bioscience International Holdings, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on OTC under the ticker CBIH.
Is Cannabis Bioscience International Holdings, Inc. profitable?
No. Over the twelve months to February 28, 2026 it reported a net loss of $515.3K on revenue of $123.6K.
How much revenue does Cannabis Bioscience International Holdings, Inc. make?
Over the twelve months to February 28, 2026 Cannabis Bioscience International Holdings, Inc. reported revenue of $123.6K. That is 64.1% less than a year earlier.
When did Cannabis Bioscience International Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on April 16, 2026. It covers the period to February 28, 2026. Its newest filing of any kind is the late annual report notice from August 31, 2026.
Similar companies
Compare CBIH with
Follow CBIH
Get an email when Cannabis Bioscience International Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CBIH: get an email when it filesWhere the numbers come from
Financial figures are the values Cannabis Bioscience International Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.